期刊文献+

替米沙坦治疗充血性心力衰竭的临床观察 被引量:5

Efficacy of Telmisartan in treatment of congestive heart failure
下载PDF
导出
摘要 目的 :观察替米沙坦治疗慢性充血性心力衰竭 (CHF)的临床疗效。方法 :经强心、利尿、扩血管等治疗 ,疗效不佳的 CHF患者 96例口服替米沙坦 4 0~ 80 mg,每天 1次 ,疗程 4周。观察治疗前后血压、心率、左室舒张末内径、左室射血分数以及心功能变化。结果 :4周治疗后血压、心率、左室舒张末内径均明显下降 (P<0 .0 5 )。左室射血分数、心排出量、心脏排血指数等各项指标均明显增加 (P<0 .0 1) ,心功能改善 ,临床总有效率达 98% ,患者耐受性好。结论 ::替米沙坦治疗 CHF疗效好。 AIM:To observe the efficacy of Telmisartan in treatment of congestive heart failure. METHODS:96 patient with heart failure, who had unsatisfactory results under conventional digitals, diuretics, vasodilators therapy, were given telmisartan 40-80mg orally once a day for 4 week. the changes of blood pressure (BP), heart rate (HR), left ventricular end diastolic dimension ( LVEDd), left ventricular ejection fraction (LVEF), cardiac output (CO), cardiac index (CI) and cardiac function (NYHA) were observed. RESULTS:4 weeks after treatment, BP, HR and LVEDd decreased significantly (P<0.05) ; LVEF, CO, and CI increased (P<0.01), cardiac function (NYHA) improved 1-2 grade. Telmisartan had few adverse effects and patients tolerance was perfect. CONCLUSION :The efficacy of Telmisartan in treatment of congestive heart failure is satisfactory.
作者 方志高
出处 《心脏杂志》 CAS 2004年第4期342-343,共2页 Chinese Heart Journal
关键词 替米沙坦 血管紧张素Ⅱ 心力衰竭 充血性 Telmisartan angiotensinⅡ heart failure,congestive
  • 相关文献

参考文献5

二级参考文献27

  • 1孙玲玲 徐成斌.今日高血压(第1版)[M].北京:中国医药科技出版社,2000.645-646.
  • 2[1]Ellestad MH, Olson WHi. Use of intravenously given ganglionic blocking agents for acute pulmonary edema [J]. JAMA, 1956, 161: 49-53.
  • 3[2]Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study [J]. N Engl J Med, 1986, 314:1547-1552
  • 4[3]Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on nortality in severe chronic heart failure. The PROMISE Study Research Group [J]. N Engl J Med, 1991, 325: 1468-1475.
  • 5[4]Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators [J]. N Engl J Med, 1991, 325: 293-302.
  • 6[5]The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severs congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Stludy (CONSENSUS) [J]. N Engl J Med, 1987, 316: 1249-1345.
  • 7[6]Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydrala-ziue-isosorbide dinitrate in the treatment of chronic congestive heart failure [J].N Engl J Med, 1991, 325: 303-310.
  • 8[7]Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group [J]. Lancet, 1993, 342: 1441-1446.
  • 9[8]Di Lenarda A, De Maria R, Gavazzi A, et al. Long-term survival effect of metoprolol in dilated cardiomyopathy. The SPIC (Italian Multicentre Cardiomyopathy Study) Group [J]. Heart, 1998, 79: 337-344.
  • 10[9]The Cardiac Insufficiency Bisoprolol Study Ⅱ (CIBIS-Ⅱ ): a randomised trial [J]. Lancet, 1999, 353: 9-13.

共引文献58

同被引文献45

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部